Patents by Inventor Scott Beacher

Scott Beacher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hyaluronidase enzyme formulations for high volume administration
    Patent number: 12178860
    Abstract: In one aspect, the present disclosure provides a formulation comprising a hyaluronidase enzyme and a therapeutically effective amount of an active ingredient. In another aspect, the present disclosure provides a method of administering a high volume of the formulation in a single administration to treat a disease or disorder in a subject.
    Type: Grant
    Filed: December 22, 2023
    Date of Patent: December 31, 2024
    Assignee: Halozyme, Inc.
    Inventors: David W. Kang, Robert J. Connor, Tara Nekoroski, Todd J. Leadens, II, Baylor Frantz, Scott Beacher, Kevin Swanson, Mike Travanty
  • Hyaluronidase Enzyme Formulations for High Volume Administration
    Publication number: 20240261376
    Abstract: In one aspect, the present disclosure provides a formulation comprising a hyaluronidase enzyme and a therapeutically effective amount of an active ingredient. In another aspect, the present disclosure provides a method of administering a high volume of the formulation in a single administration to treat a disease or disorder in a subject.
    Type: Application
    Filed: April 22, 2024
    Publication date: August 8, 2024
    Applicant: Halozyme, Inc.
    Inventors: David W. KANG, Robert J. CONNOR, Tara NEKOROSKI, Todd J. LEADENS, II, Baylor FRANTZ, Scott BEACHER, Kevin SWANSON, Mike TRAVANTY
  • Hyaluronidase Enzyme Formulations for High Volume Administration
    Publication number: 20240207375
    Abstract: In one aspect, the present disclosure provides a formulation comprising a hyaluronidase enzyme and a therapeutically effective amount of an active ingredient. In another aspect, the present disclosure provides a method of administering a high volume of the formulation in a single administration to treat a disease or disorder in a subject.
    Type: Application
    Filed: December 22, 2023
    Publication date: June 27, 2024
    Applicant: Halozyme Inc.
    Inventors: David W. KANG, Robert J. Connor, Tara Nekoroski, Todd J. Leadens, II, Baylor Frantz, Scott Beacher, Kevin Swanson, Mike Travanty
  • Injection device
    Patent number: D1042806
    Type: Grant
    Filed: December 22, 2022
    Date of Patent: September 17, 2024
    Assignee: HALOZYME, INC.
    Inventors: Todd J. Leadens, II, Baylor Frantz, Scott Beacher, Kevin Swanson, Mike Travanty